[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025",
    "summary": "We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks with potential to explode in 2025. The recent pullback in US equities can be a sign of an aging bull market and […]",
    "url": "https://finnhub.io/api/news?id=397976f6f25b73cc209de384aa54029bbbd254ac03bbbe86b4bca5cddd520d8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742823152,
      "headline": "Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025",
      "id": 133338226,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks with potential to explode in 2025. The recent pullback in US equities can be a sign of an aging bull market and […]",
      "url": "https://finnhub.io/api/news?id=397976f6f25b73cc209de384aa54029bbbd254ac03bbbe86b4bca5cddd520d8b"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst performers in the therapeutics industry.",
    "url": "https://finnhub.io/api/news?id=bd1bb2332645bd43ba7bdf3c866c27086431f85b17a09a3641424158140bcc55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742806869,
      "headline": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
      "id": 133337822,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst performers in the therapeutics industry.",
      "url": "https://finnhub.io/api/news?id=bd1bb2332645bd43ba7bdf3c866c27086431f85b17a09a3641424158140bcc55"
    }
  }
]